Kamada Ltd. Logo

Kamada Ltd.

KMDA | TA

Overview

Corporate Details

ISIN(s):
IL0010941198
LEI:
Country:
Israel
Address:
2 Holzman St, Science Park, 7670402 Rehovot
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kamada Ltd. is a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. The company develops, produces, and markets a portfolio of pharmaceuticals for rare and serious conditions, utilizing a proprietary platform technology for the extraction and purification of proteins from human plasma. Its key therapeutic areas include Alpha-1 Antitrypsin Deficiency (AATD), rabies prophylaxis, and prevention of cytomegalovirus (CMV) in transplant recipients. Kamada maintains a diverse portfolio of marketed products and a robust development pipeline, supported by industry-leading manufacturing and protein separation capabilities.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Kamada Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-13 16:00
Foreign Filer Report
Second Quarter and First Half 2025 Financial Results
English 4.1 MB
2025-08-13 16:00
Foreign Filer Report
Second Quarter and First Half 2025 Financial Results
English 36.8 KB
2025-08-11 16:00
Foreign Filer Report
FDA Approval of its Plasma Collection Center in Houston, Texas
English 184.4 KB
2025-08-11 16:00
Report Publication Announcement
FDA Approval of its Plasma Collection Center in Houston, Texas
English 36.5 KB
2025-08-06 16:05
Foreign Filer Report
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Result…
English 155.6 KB
2025-08-06 16:05
Foreign Filer Report
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Result…
English 36.5 KB
2025-08-05 17:33
Regulatory News Service
Due to an error, trade halt was initiated in KAMADA's shares instead of CAMTEK'…
Hebrew (modern) 62.0 KB
2025-06-17 16:00
Foreign Filer Report
Kamada Confirms Continuous Global Business Operations and Products Availability…
English 134.2 KB
2025-06-17 16:00
Regulatory News Service
Kamada Confirms Continuous Global Business Operations and Products Availability…
English 36.6 KB
2025-05-14 16:00
Foreign Filer Report
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
English 8.4 MB
2025-05-14 16:00
Earnings Release
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
English 36.5 KB
2025-05-07 16:00
Foreign Filer Report
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
English 151.4 KB
2025-05-07 16:00
Report Publication Announcement
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
English 36.3 KB
2025-05-05 16:00
Foreign Filer Report
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for …
English 178.4 KB
2025-05-05 16:00
Foreign Filer Report
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for …
English 36.5 KB

Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Kamada Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Otsuka Holdings Co., Ltd. Logo Japan 4578
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
PAION AG Logo
Developed innovative drugs for hospital sedation, anesthesia, and critical care.
Germany PA8
PeptiDream Inc. Logo Japan 4587
PEPTONIC Medical AB Logo
Develops clinically proven self-care products and diagnostics for women's intimate health.
Sweden PMED
Perseus Proteomics Inc. Logo Japan 4882
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain PHM
Pharmanutra Logo
Develops science-backed nutraceuticals & pharmaceuticals for nutritional & joint health.
Italy PHN
PharmaSGP Holding SE Logo
Develops & distributes natural, pharmacy-exclusive OTC drugs for chronic conditions in Europe.
Germany PSG
Pharmena S.A. Logo
Develops patented 1-MNA molecule for dermocosmetics and supplements in EU & North American markets.
Poland PHR